Evoke Pharma Inc (EVOK) Quote

EVOK new 52 week low

EVOK new 52 week low

Same here with me! I never caught COVID but 2 of my children did and my daughter-in-law, in fact,1 of them had it twice.
Had a fantastic 2020 and 2021 and made coins on several OTC stocks. I think the good investments for 2022 and 2023 are in these NASDAQ Micro Caps but we shall see.
It's great to catch up with you Pedro and let's stay in touch this time bro! :)

Wow. Good to hear from you again. Yes, it's been a long time.

I have been doing okay. Same-o-same-o as the months pass. I haven't caught COVID yet. But my Family has. I guess I have been lucky (knock on wood).

I made some money on the market, and I lost some money on the market. I only drop by IHUB once in awhile. I always find IHUB a good research tool in reviewing old posts -- to see what people were saying about the stock in the past.

EVOK caught my eye premarket yesterday. But it was trading irregularly. I dropped by to see what other people wrote about the company. I bought on the pullback...but it pulled-back more. Lost some money here yesterday.

I hope you and your Family are doing great.

Pedro! Hey dude. Haven't spoken to you since the year of the flood. How have you been doing???????

Yes, the whole market is going crazy right now (sea of red).
I ended-up with a small loss on this company. I have no desire to get back-in.

EVOK:Were green in a sea of RED

Yep, looks like this was a pump-and-dump PR. I hope I'm wrong.

I have my finger on the button, ready to buy. Just waiting to see how this trades at open.

That's everyday with every ticker... rockets in the early hours and very few continually surge into close

I like the bounce. But there's something weird about the premarket trading. As if today's great PR will end-up with Insiders dumping and an organized Wolf-Pack (short-attack).

Evoke Pharma Announces Approval of GIMOTI® to Florida State Medicaid Program
June 15, 2022 08:30 ET | Source: Evoke Pharma, Inc.




...
SOLANA BEACH, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that the Florida Medicaid Pharmaceutical & Therapeutics Committee has approved adding GIMOTI, the Company’s novel treatment solution meant to treat symptoms associated with acute and recurrent diabetic gastroparesis, to the Florida Medicaid Preferred Drug List (PDL) effective immediately.

To prescribe Gimoti under the plan, healthcare providers need to attest to the patient being at least 18 years of age, having a diagnosis of diabetic gastroparesis, and being unable to use oral metoclopramide. These criteria are typical for Gimoti coverage under state Medicaid programs and consistent with Company expectations for utility in helping patients who suffer from this debilitating disease. Patients taking oral metoclopramide are often unable to achieve relief due to a delay in gastric emptying and erratic absorption of oral medication. We believe many patients can benefit from the novel nasal delivery of Gimoti to treat symptoms such as nausea, vomiting and abdominal pain. The Florida Medicaid formulary and related programs provide healthcare to approximately 5 million beneficiaries.

With this addition, we are building a strong foundation and momentum for positive access to GIMOTI within Medicaid lives in the US. “We view this addition to the Florida Medicaid PDL as a win for patient access to this important medicine for diabetic gastroparesis patients, who have very limited options to obtain symptomatic relief. In a world where many new products are excluded from formularies and patient access is denied, this decision is a significant commercial milestone for GIMOTI,” stated Matt D’Onofrio, MBA, Evoke Pharma’s Chief Business Officer. “Medicaid approvals across various jurisdictions are one of the primary components of our business plan to increase GIMOTI access. With this addition, we believe we are steadily executing the right strategies to ensure that healthcare providers around the country have the option to make GIMOTI the standard of care for diabetic gastroparesis.”

About Evoke Pharma, Inc.

Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults.

Diabetic gastroparesis is a GI disorder affecting millions of patients worldwide, in which the stomach takes too long to empty its contents resulting in serious GI symptoms as well as other systemic complications. The gastric delay caused by gastroparesis can compromise absorption of orally administered medications. Prior to FDA approval to commercially market GIMOTI, metoclopramide was only available in oral and injectable formulations and remains the only drug currently approved in the United States to treat gastroparesis. Visit www.EvokePharma.com for more information.

Follow GIMOTI on Facebook: https://www.facebook.com/GIMOTI-metoclopramide-nasal-spray-104672345100289
Follow Evoke Pharma on Facebook: https://www.facebook.com/Evoke-Pharma-Inc-131313647029724

Filled gap up now on a slow climb waiting on partnership/license deal news.

Bs games!! It will go back up. Lol

Omg what the hell… why did this drop like this?!?! I really do like what I see…

I sold in the premarket…r/s 1/12 next..

Proven product.

Proven revenues.

And now FDA has granted exclusivity.

This is going to multi dollars.

Stock is an unbelievable value with this dip.

This will go up today and produce a strong close.

Buyers will come to get the bargain prices.

LOAD UP….Eversana buyout might happen

Rumor is solid

Makes sense.

,,,,,,,Ok nowww AH you should buy.62

$EVOK:

i tripled my position in this stock.

this is a damn gift under $1.


just a matter of time before this is trading around $2.

I'll take my .66!!

,,,,,,,,Wait to buy after the meeting.

Fantastic dip buy opportunity.

This stock is not going to be under $1 much longer.

This will explode past $1 fairly rapidly.

News is quite big.

I hear you,,,,God bless you brother. HANG IN THERE!

Thanks for sharing
And putting this into perspective
Go EVOK

,,,,,,,GOOD MORNING! ROCK N ROLL>>>>$2+

1.01 ^ 0.15 (17.44%)

never been diagnosed.. use to run to the emergency rooms 3 or 4 times a year ..upper gi series lower gi series. rinse and repeat and they could find nothing. thats 1974.....i have learned how to eat and how to medicate. best place for me to live in country where you can get the drug you need and avoid the middleperson aka doctor.... just walk into a pharmacy and say ill take this or that. ill never get my hands on this nasal medication because they will want me to take 10 tests to make sure i need it and they will find a blanking tumor or something,,,its a worm hole.. you are not allowed to die in america....id try the stuff if i could buy it like aspirin..gl ......... trapped in evok ????

Wow I’ll take 25k 70’s AH

Really??? We’re you diagnosed recently

i may or may not make money here but i have just read in that news release what i have been plagued by for 40 years. food sits in my stomach and rots. what takes a normal person 3 hours to digest takes me 7... im gonna get my hands on this that is of course if the medical community doesnt make me jump thrugh a zillion tests to prescribe it

it is building support just above $1.

looking for a $1.50 close and $2 in after hours trading.


https://finance.yahoo.com/news/evoke-pharma-granted-fda-market-123000938.html



this is quite huge.

Having trouble holding 1.00 salayaa

This will hit $2 after hours.

Looking for a very strong open in the morning.

,,,,,,,GASTEROPARITIS IS LINKED TO DIABETES..(WEN..MOON??)

Good dip buy opportunity.

FDA granted exclusivity is a huge development for this company for this vital drug.

This will go on to produce 600 percent to 1000 percent gains on the strength of this huge news.

,,,,,,,Any buy under .92 ur fine!

Keeps dipping. Dip buy was 1.10 lol

well i donated today...hopefully to someone who needed it

excellent dip buy opportunity.


this is likely to jump 500% this week.



https://finance.yahoo.com/news/evoke-pharma-granted-fda-market-123000938.html




this is absolutely huge.

Damn

News

What drove this close to six dollars a few years ago, and why did it collapse?

Anti-COVID nasal spray could protect against infection for up to 8 hrs.

Makin money today!
Based on the just reported quarter there is hope! They got a good shot.

Trigger finger getting itchy...

Should have pulled it around 1.81...this could be the start of the turn around...looks like it has bottomed to me...I think but i'm not quite sure...could still dip lower but it looks like the start of an uptrend, need volume...

Good for you. I hold too many shares, with big loss. Cannot get rid of it so easy.

If I wasn’t confident I would sell it and move on. I still own it and have added. But it is a small position for me. I like others better but I always like to own a few little biotechs.

https://www.proxydocs.com/branding/963686/edocs/2020/issuer/

To consider and vote upon the approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 50,000,000 to 100,000,000;

Register and vote "NO" to the dilution.